Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
101.22%
-
Total 13F principal
-
$207,530,234
-
Principal change
-
+$14,711,624
-
Total reported market value
-
$210,897,141
-
Number of holders
-
49
-
Value change
-
+$12,815,532
-
Number of buys
-
16
-
Number of sells
-
29
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q1 2020
As of 31 Mar 2020,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
49 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$207,530,234
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., MACKAY SHIELDS LLC, D. E. Shaw & Co., Inc., STATE STREET CORP, SONORA INVESTMENT MANAGEMENT, LLC, Man Group plc, CSS LLC/IL, BNP PARIBAS ASSET MANAGEMENT Holding S.A., FMR LLC, and DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main.
This page lists
49
institutional bondholders reporting positions
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.